FLUPENTIXOL DECANOATE INJECTION BP 100 MG
FLUPENTIXOL DECANOATE : 100 MG · DIN 02331721 · SANDOZ CANADA INCORPORATED
Health Canada status: CANCELLED POST MARKET
What is FLUPENTIXOL DECANOATE INJECTION BP?
FLUPENTIXOL DECANOATE INJECTION BP 100 MG contains FLUPENTIXOL DECANOATE : 100 MG. It is listed in the Health Canada Drug Product Database under DIN 02331721, held by SANDOZ CANADA INCORPORATED, supplied as SOLUTION for INTRAMUSCULAR administration. Health Canada currently lists it as cancelled post market, status dated 08-Apr-2021. Nexara Health is a licensed Canadian wholesale distributor (DEL 3-002896-A) and can source this product for hospitals, pharmacies and clinics. Availability and lead time are confirmed per order.
Product details and regulatory record
| DIN | 02331721 |
|---|---|
| Brand name | FLUPENTIXOL DECANOATE INJECTION BP |
| Generic / active ingredient | FLUPENTIXOL DECANOATE : 100 MG |
| Manufacturer | SANDOZ CANADA INCORPORATED |
| Strength | 100 MG |
| Dosage form | SOLUTION |
| Route of administration | INTRAMUSCULAR |
| Schedule | Prescription |
| ATC code | N05AF01 FLUPENTIXOL |
| AHFS class | 08:18.32 |
| Biosimilar | No |
| Health Canada status | CANCELLED POST MARKET |
| Status date | 08-Apr-2021 |
| Original market date | 2010-07-27 00:00:00 |
What can be used instead?
Other Canadian products sharing ATC code N05AF01 FLUPENTIXOL. 4 of 10 DINs in this group are currently marketed — marketed products are listed first, because that is what can actually be bought. These tables describe supply, not clinical equivalence: substitution rests with the prescriber or pharmacist, and interchangeability is determined provincially.
| Product | Strength | Form | Manufacturer | Health Canada status | DIN |
|---|---|---|---|---|---|
| FLUANXOL 0.5MG - TAB | 0.5 MG | TABLET | LUNDBECK CANADA INC | MARKETED | DIN 02156008 |
| FLUANXOL 3MG - TAB | 3 MG | TABLET | LUNDBECK CANADA INC | MARKETED | DIN 02156016 |
| FLUANXOL DEPOT 10%- LIQ IM 100MG/ML | 100 MG | SOLUTION | LUNDBECK CANADA INC | MARKETED | DIN 02156040 |
| FLUANXOL DEPOT 2% -LIQ IM 20MG/ML | 20 MG | SOLUTION | LUNDBECK CANADA INC | MARKETED | DIN 02156032 |
| FLUANXOL DEPOT INJ 100MG/ML | 100 MG | LIQUID | MERRELL DOW PHARMACEUTICALS (CANADA) INC., DIVISION OF MMDC | CANCELLED POST MARKET | DIN 00524530 |
| FLUANXOL DEPOT INJ 20MG/ML | 20 MG | LIQUID | MERRELL DOW PHARMACEUTICALS (CANADA) INC., DIVISION OF MMDC | CANCELLED POST MARKET | DIN 00524522 |
| FLUANXOL TAB 0.5MG | 0.5 MG | TABLET | MERRELL DOW PHARMACEUTICALS (CANADA) INC., DIVISION OF MMDC | CANCELLED POST MARKET | DIN 00580619 |
| FLUANXOL TAB 3MG | 3 MG | TABLET | MERRELL DOW PHARMACEUTICALS (CANADA) INC., DIVISION OF MMDC | CANCELLED POST MARKET | DIN 00585157 |
| FLUPENTIXOL DECANOATE INJECTION BP | 20 MG | SOLUTION | SANDOZ CANADA INCORPORATED | CANCELLED PRE MARKET | DIN 02331713 |
Who else supplies FLUPENTIXOL worldwide?
Nexara tracks national medicine registries and published price lists across multiple markets. FLUPENTIXOL appears in 25 registered pack listings across 9 markets, published on 8 different national price bases. Where a Canadian route is closed, that is where an alternative route of supply starts — subject to the import rules in both countries.
Registered listings are not stock. Ask us to confirm what can actually be sourced for your order.
Can this still be bought in Canada?
No. This Drug Identification Number is cancelled post market in Health Canada's Drug Product Database, so the product is no longer authorized for sale in Canada and Nexara does not supply it. This page is kept as a regulatory record.
If you are looking for a current equivalent, the alternatives above list every product sharing this therapeutic class, with the marketed ones first. Ask us to source an alternative
Ordering questions
Who can buy this from Nexara?
Licensed entities only. Nexara holds Health Canada establishment licence DEL 3-002896-A and ships only to a licensed address.
Is there a minimum order?
Yes, set per product line and per pack multiple rather than on the order total, so you are never asked to buy a part-pack. The minimum for this line is confirmed with your quote.
What is the lead time?
Confirmed per order at quotation, and it depends on current stock position and whether the product is in shortage.
Can Nexara supply this for a clinical trial?
Yes — comparator and background-therapy supply, including sourcing from other markets where a Canadian pack will not satisfy the protocol. Clinical trial supply.